Toxicological profile using mass spectrometry in sudden cardiac arrest survivors admitted to a tertiary centre
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Toxicological profile using mass spectrometry in sudden cardiac arrest survivors admitted to a tertiary centre. / Stampe, Niels Kjær; Glinge, Charlotte; Rasmussen, Brian Schou; Bhardwaj, Priya; Linnet, Kristian; Jabbari, Reza; Paludan-Müller, Christian; Hassager, Christian; Kjærgaard, Jesper; Tfelt-Hansen, Jacob; Winkel, Bo Gregers.
I: Resuscitation, Bind 198, 110197, 2024.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Toxicological profile using mass spectrometry in sudden cardiac arrest survivors admitted to a tertiary centre
AU - Stampe, Niels Kjær
AU - Glinge, Charlotte
AU - Rasmussen, Brian Schou
AU - Bhardwaj, Priya
AU - Linnet, Kristian
AU - Jabbari, Reza
AU - Paludan-Müller, Christian
AU - Hassager, Christian
AU - Kjærgaard, Jesper
AU - Tfelt-Hansen, Jacob
AU - Winkel, Bo Gregers
N1 - Publisher Copyright: © 2024 Elsevier B.V.
PY - 2024
Y1 - 2024
N2 - Background: There has been no previous thorough toxicological examination of a cohort of patients with resuscitated sudden cardiac arrest. We aimed to determine the qualitative and quantitative drug composition in a resuscitated sudden cardiac arrest population, using forensic toxicology, with focus on prescribed, non-prescribed, and commonly abused drugs. Methods: Individuals aged 18–90 years with resuscitated sudden cardiac arrest of presumed cardiac causes were prospectively included from a single tertiary center. Data from the sudden cardiac arrest hospitalization was collected from medical reports. Drugs used during resuscitation or before the blood sampling were identified and excluded in each patient. Mass spectrometry-based toxicology was performed to determine the absence or presence of most drugs and to quantify the findings. Results: Among 186 consecutively enrolled resuscitated sudden cardiac arrest patients (median age 62 years, 83% male), 90% had a shockable rhythm, and were primarily caused by ischemic heart disease (66%). In total, 90 different drugs (excluding metabolites) were identified, and 82% of patients had at least one drug detected (median of 2 detected drugs (IQR:1–4)) (polypharmacy). Commonly abused drugs were present in 16%, and QT-prolonging drugs were present in 12%. Polypharmacy (≥5drugs) were found in 19% of patients. Importantly, none had potentially lethal concentrations of any drugs. Conclusion: In resuscitated sudden cardiac arrest patients with cardiac arrest of presumed cardiac cause, routine toxicological screening provides limited extra information. However, the role of polypharmacy in sudden cardiac arrest requires further investigation. No occult overdose-related cardiac arrests were identified.
AB - Background: There has been no previous thorough toxicological examination of a cohort of patients with resuscitated sudden cardiac arrest. We aimed to determine the qualitative and quantitative drug composition in a resuscitated sudden cardiac arrest population, using forensic toxicology, with focus on prescribed, non-prescribed, and commonly abused drugs. Methods: Individuals aged 18–90 years with resuscitated sudden cardiac arrest of presumed cardiac causes were prospectively included from a single tertiary center. Data from the sudden cardiac arrest hospitalization was collected from medical reports. Drugs used during resuscitation or before the blood sampling were identified and excluded in each patient. Mass spectrometry-based toxicology was performed to determine the absence or presence of most drugs and to quantify the findings. Results: Among 186 consecutively enrolled resuscitated sudden cardiac arrest patients (median age 62 years, 83% male), 90% had a shockable rhythm, and were primarily caused by ischemic heart disease (66%). In total, 90 different drugs (excluding metabolites) were identified, and 82% of patients had at least one drug detected (median of 2 detected drugs (IQR:1–4)) (polypharmacy). Commonly abused drugs were present in 16%, and QT-prolonging drugs were present in 12%. Polypharmacy (≥5drugs) were found in 19% of patients. Importantly, none had potentially lethal concentrations of any drugs. Conclusion: In resuscitated sudden cardiac arrest patients with cardiac arrest of presumed cardiac cause, routine toxicological screening provides limited extra information. However, the role of polypharmacy in sudden cardiac arrest requires further investigation. No occult overdose-related cardiac arrests were identified.
KW - Drugs
KW - Forensic toxicology
KW - Polypharmacy
KW - Sudden cardiac arrest (SCA)
U2 - 10.1016/j.resuscitation.2024.110197
DO - 10.1016/j.resuscitation.2024.110197
M3 - Journal article
C2 - 38582441
AN - SCOPUS:85190100812
VL - 198
JO - Resuscitation
JF - Resuscitation
SN - 0300-9572
M1 - 110197
ER -
ID: 389506848